WO2005044215A1 - Foamed skin cream - Google Patents

Foamed skin cream Download PDF

Info

Publication number
WO2005044215A1
WO2005044215A1 PCT/IB2003/005006 IB0305006W WO2005044215A1 WO 2005044215 A1 WO2005044215 A1 WO 2005044215A1 IB 0305006 W IB0305006 W IB 0305006W WO 2005044215 A1 WO2005044215 A1 WO 2005044215A1
Authority
WO
WIPO (PCT)
Prior art keywords
foam according
cream
skin foam
cream skin
skin
Prior art date
Application number
PCT/IB2003/005006
Other languages
German (de)
French (fr)
Inventor
Frank Grossmann
Hans Hegetschweiler
Original Assignee
Medena Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medena Ag filed Critical Medena Ag
Priority to PCT/IB2003/005006 priority Critical patent/WO2005044215A1/en
Priority to AU2003274610A priority patent/AU2003274610A1/en
Publication of WO2005044215A1 publication Critical patent/WO2005044215A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the present invention relates to a cream skin foam.
  • Foams are a popular form of application in cosmetics because they are easy to handle.
  • a skin foam has e.g. compared to a skin cream
  • the advantage is that it penetrates the skin more quickly and is therefore not perceived as greasy by the user.
  • Skin foams are applied to the skin to protect them from harmful influences such as caused by detergents, protect them or administer nourishing agents that contribute to skin regeneration.
  • the object of the present invention is to provide a cream skin foam with good skin tolerance on a natural basis.
  • the cream skin foam of the present invention is obtainable by a process which comprises the following steps: a) Production of an oil phase by melting at 70-80 ° C. of a mixture comprising fatty acids, preferably C5-C22 fatty acids, fatty alcohols and optionally one or more oil components; b) Preparation of a water phase at 70-80 ° C comprising humectants, emulsifiers and co-emulsifiers in water; c) combining and emulsifying the water phase of step b) with the oil phase of step a) at 70-80 ° C; d) partial saponification of the mixture obtained in c) at 70-80 ° C; e) adjusting the pH of the mixture from d) to 5.0 to 6.0 and f) assembling the mixture from e) by adding a propellant.
  • the following steps a) Production of an oil phase by melting at 70-80 ° C. of a mixture comprising fatty acids, preferably C5-C
  • Oil components of the oil phase in step a) selected from fatty acid esters, oils, mono-, di- and triglycerides.
  • the oils in the oil phase of step a) are preferably selected from the group consisting of almond oil, evening primrose oil, wheat germ oil and dicapryl ether.
  • the oil phase of step a) comprises stearic acid.
  • Preferred triglycerides of the oil phase of step a) are selected from the group consisting of caprylic acid, capric acid and stearic acid triglycerides.
  • the oil phase of step a) preferably comprises the fatty alcohol cetearyl alcohol.
  • Preferred fatty acid esters of the oil phase of step a) are coco-caprylate and coco-caprate.
  • the preparation of the oil phase in step a) and / or the production of the water phase in step b) and / or the combination and emulsification in step c) and / or the partial saponification in step d) takes place at 75 ° C. instead of.
  • active substances in particular allantoin, are added to the mixture after step c).
  • Preferred humectants for use in the water phase of step b) are glycerol and propylene glycol.
  • Preferred emulsifiers or co-emulsifiers for use in the water phase of step b) are triceteareth-4 phosphate and sodium lauroyl sarcosinate.
  • the partial saponification in step d) is carried out using aminomethylpropanol or triethanolamine, preferably by stirring for 30 minutes.
  • the pH in step e) is preferably set by adding a lactic acid / sodium hydroxide buffer.
  • the temperature of the mixture is preferably below 30 ° C, more preferably 25 ° C.
  • the assembly takes place in step f) by adding propane and / or butane.
  • Preferred percentage ranges for the oil phase and the water phase of the cream skin foam of the present invention are as follows: oil phase 15 to 35% water phase ad 100%.
  • the oil phase preferably contains 1-16% fatty acids and 0.1-5% fatty acid esters.
  • the remaining oil components can be added in any amount.
  • the water phase preferably contains 0.1-5% emulsifiers.
  • a cream skin foam of the present invention is distinguished by excellent skin tolerance, since it has a pH of 5.0 to 6.0.
  • a cream of skin foam with a pH of 5.5 is particularly preferred.
  • the advantage of the cream skin foam according to the invention lies in the maintenance of the physiological buffering capacity of the skin for the protection of bacterial and fungal infections while maintaining the natural bacterial skin flora and the integument.
  • the partial saponification of the mixture in step d) means that the fatty acids of the creme skin foam are largely present as natural fatty acids, which corresponds to the composition of the physiological fat film of the skin. In the case of total saponification, the fatty acids would be present as soap (surfactants).
  • the cream skin foams according to the invention can, in addition to the components described above, other Contain substances such as nourishing, skin-soothing, circulation-promoting, antifungal, moisturizing or odor-absorbing substances.
  • the exact composition of the skin foam cream depends on its use.
  • the cream skin foam according to the invention is also suitable for the care of healthy, irritated, dry, cracked, flaky skin or skin damaged in defense behavior.
  • Another area of application of the cream skin foam is the treatment of skin irritation and / or
  • the prevention of skin infections caused by fungi, spores or pathological microbial colonization, in particular bacteria, or the care of the skin after a skin infection has been achieved can be achieved with the skin foam cream according to the invention.
  • the cream skin foam can also help to promote blood circulation to the skin and / or to improve the complexion. For this purpose, he preferably receives herbal active ingredients.
  • the oil phase contains the following components (% w / w): Miglyol 812 3, .4% Cetiol OE 1. .3% almond oil Suess Pharm 31433 3, .4% wheat germ oil 2010 1. .3% Cetiol LC 2. .6% Cuttina MD-V 1. .8% Lanette 0 Ph. Eur. 4.2% Edenor C 18 4.6% Evening Primrose Oil 2.0% Hostphat KW 340 D 0.9% Total 25.5%

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

A foamed skin cream is produced by a method comprising the following steps: (a) preparation of an oil phase by melting at 70-80 °C a mixture of fatty acids, preferably C6-C22 fatty acids, fatty alcohols and one or more optional oil components; (b) preparation of an aqueous phase at 70-80° comprising moisturisers, emulsifiers and co-emulsifiers in water; (c) blending and emulsifying the aqueous phase from step (b) with the oil phase from step (a) at 70-80 °C; (d) partial saponification of the mixture produced in (c) at 70-80 °C; (e) adjustment of the pH value of the mixture from (d) at 5.0 to 6.0; and (f) preparation of the mixture from (e) by admixture of a foaming gas.

Description

Creme Hautschäum Cream skin foam
Hintergrund Die vorliegende Erfindung betrifft einen Creme Hautschäum.Background The present invention relates to a cream skin foam.
Stand der Technik Schäume sind in der Kosmetik eine beliebte Anwendungsform, da sich diese leicht handhaben lassen. Ein Hautschaum hat z.B. gegenüber einer Hautcreme denState of the art Foams are a popular form of application in cosmetics because they are easy to handle. A skin foam has e.g. compared to a skin cream
Vorteil, dass dieser rascher in die Haut einzieht und somit vom Anwender nicht als fettend empfunden wird. Hautschäume werden auf die Haut aufgetragen, um diese vor schädlichen Einflüssen wie sie z.B. durch Reinigungsmit- tel verursacht werden, zu schützen oder pflegende Wirkstoffe zu verabreichen, die zur Hautregenerierung beitragen. Aufgabe der vorliegenden Erfindung ist es einen Creme Hautschaum mit einer guten Hautverträglichkeit bei natürlicher Grundlage zur Verfügung zu stellen.The advantage is that it penetrates the skin more quickly and is therefore not perceived as greasy by the user. Skin foams are applied to the skin to protect them from harmful influences such as caused by detergents, protect them or administer nourishing agents that contribute to skin regeneration. The object of the present invention is to provide a cream skin foam with good skin tolerance on a natural basis.
Darstellung der Erfindung Der Creme Hautschaum der vorliegenden Erfindung ist erhältlich durch ein Verfahren, das folgende Schritte umfasst: a) Herstellung einer Olphase durch Aufschmelzen bei 70- 80°C einer Mischung umfassend Fettsäuren, bevorzugt C5- C22 Fettsäuren, Fettalkohole und optional eine oder mehrere Ölkomponenten; b) Herstellung einer Wasserphase bei 70-80 °C umfassend Feuchthaltemittel, Emulgatoren und Coemulgatoren in Wasser; c) Vereinigung und Emulgierung der Wasserphase des Schritts b) mit der Olphase des Schritts a) bei 70- 80°C; d) Teilverseifung der in c) erhaltenen Mischung bei 70- 80°C; e) Einstellung des pH Werts der Mischung aus d) auf 5.0 bis 6.0 und f) Konfektionieren der Mischung aus e) durch Zugabe eines Treibgases . In einer bevorzugten Ausführungsform sind dieDESCRIPTION OF THE INVENTION The cream skin foam of the present invention is obtainable by a process which comprises the following steps: a) Production of an oil phase by melting at 70-80 ° C. of a mixture comprising fatty acids, preferably C5-C22 fatty acids, fatty alcohols and optionally one or more oil components; b) Preparation of a water phase at 70-80 ° C comprising humectants, emulsifiers and co-emulsifiers in water; c) combining and emulsifying the water phase of step b) with the oil phase of step a) at 70-80 ° C; d) partial saponification of the mixture obtained in c) at 70-80 ° C; e) adjusting the pH of the mixture from d) to 5.0 to 6.0 and f) assembling the mixture from e) by adding a propellant. In a preferred embodiment, the
Ölkomponenten der Olphase im Schritt a) ausgewählt aus Fettsäureestern, Ölen, Mono-, Di- und Triglyceriden. Die Öle der Olphase des Schritts a) sind bevorzugt ausgewählt aus der Gruppe bestehend aus Mandelöl, Nachtkerzenöl, Weizenkeimöl , Dicaprylether . In einer weiteren bevorzugten Ausführungsform umfasst die Olphase des Schritts a) Stearinsäure. Bevorzugte Triglyceride der Olphase des Schritts a) sind ausgewählt aus der Gruppe bestehend aus Caprylsäure- , Caprinsäure- und Stearinsäuretriglyceriden. Die Olphase des Schritts a) umfasst bevorzugt den Fettalkohol Cetearylalkohol . Bevorzugte Fettsäureester der Olphase des Schritts a) sind Coco-Caprylat und Coco-Caprat. In einer weiteren bevorzugten Ausführungsform findet die Herstellung der Olphase im Schritt a) und/oder die Herstellung der Wasserphase im Schritt b) und/oder die Vereinigung und E ulgierung im Schritt c) und/oder die Teilverseifung im Schritt d) bei 75°C statt. In einer weiteren bevorzugten Ausführungsform werden nach dem Schritt c) der Mischung Wirkstoffe zugegeben, insbesondere Allantoin. Bevorzugte Feuchthaltemittel zur Verwendung in der Wasserphase des Schritts b) sind Glycerin und Pro- pylenglycol. Bevorzugte Emulgatoren bzw. Coemulgatoren zur Verwendung in der Wasserphase des Schritts b) sind Triceteareth-4 Phosphat und Natriumlauroylsarkosinat . In einer weiteren bevorzugten Ausführungsform wird die Teilverseifung im Schritt d) mittels Aminome- thylpropanol oder Triethanolamin durchgeführt, bevorzugt durch Ausrühren für 30 Minuten. Die Einstellung des pH-Wertes im Schritt e) geschieht bevorzugt durch Zugabe eines Milchsäure/ Natronlauge Puffers. Für die Einstellung des pH Wertes liegt die Temperatur der Mischung bevorzugt unter 30°C, bevorzugter bei 25°C. In einer weiteren bevorzugten Ausführungsform geschieht die Konfektionierung im Schritt f) durch Zugabe von Propan und/oder Butan. Bevorzugte Prozentbereiche für die Olphase und die Wasserphase des Creme Hautschaums der vorliegenden Erfindung sind wie folgt: Olphase 15 bis 35 % Wasserphase ad 100%. Die Olphase enthält bevorzugt 1-16% Fettsäuren und 0.1-5% Fettsäureester. Die restlichen Ölkomponen- ten können in beliebigen Mengen zugegeben werden. Die Wasserphase enthält bevorzugt 0.1-5% Emulgatoren.Oil components of the oil phase in step a) selected from fatty acid esters, oils, mono-, di- and triglycerides. The oils in the oil phase of step a) are preferably selected from the group consisting of almond oil, evening primrose oil, wheat germ oil and dicapryl ether. In a further preferred embodiment, the oil phase of step a) comprises stearic acid. Preferred triglycerides of the oil phase of step a) are selected from the group consisting of caprylic acid, capric acid and stearic acid triglycerides. The oil phase of step a) preferably comprises the fatty alcohol cetearyl alcohol. Preferred fatty acid esters of the oil phase of step a) are coco-caprylate and coco-caprate. In a further preferred embodiment, the preparation of the oil phase in step a) and / or the production of the water phase in step b) and / or the combination and emulsification in step c) and / or the partial saponification in step d) takes place at 75 ° C. instead of. In a further preferred embodiment, active substances, in particular allantoin, are added to the mixture after step c). Preferred humectants for use in the water phase of step b) are glycerol and propylene glycol. Preferred emulsifiers or co-emulsifiers for use in the water phase of step b) are triceteareth-4 phosphate and sodium lauroyl sarcosinate. In a further preferred embodiment, the partial saponification in step d) is carried out using aminomethylpropanol or triethanolamine, preferably by stirring for 30 minutes. The pH in step e) is preferably set by adding a lactic acid / sodium hydroxide buffer. To adjust the pH, the temperature of the mixture is preferably below 30 ° C, more preferably 25 ° C. In a further preferred embodiment, the assembly takes place in step f) by adding propane and / or butane. Preferred percentage ranges for the oil phase and the water phase of the cream skin foam of the present invention are as follows: oil phase 15 to 35% water phase ad 100%. The oil phase preferably contains 1-16% fatty acids and 0.1-5% fatty acid esters. The remaining oil components can be added in any amount. The water phase preferably contains 0.1-5% emulsifiers.
Weg(e) zur Ausführung der ErfindungWay (s) of carrying out the invention
Ein Creme Hautschaum der vorliegenden Erfindung zeichnet sich durch eine ausgezeichnete Hautverträglichkeit aus, da dieser einen pH-Wert von 5.0 bis 6.0 aufweist. Besonders bevorzugt ist eine Creme Hautschaum mit einem pH-Wert von 5.5. Der Vorteil des erfindungsge- mässen Creme Hautschaums liegt im Erhalt der physiologischen Pufferkapazität der Haut zum Schutz von bakteriellen und Pilzinfektionen unter Beibehaltung der natürlichen bakteriellen Hautflora und des Integuments . Die Teilverseifung der Mischung im Schritt d) führt dazu, dass die Fettsäuren des Creme Hautschaums zum grössten Teil als natürliche Fettsäuren vorliegen, was der Zusammensetzung des physiologischen Fettfilms der Haut entspricht. Bei einer Totalverseifung würden die Fettsäuren als Seife (Tenside) vorliegen. Die erfindungsgemässen Creme Hautschäume können neben den oben beschriebenen Bestandteilen weitere Stoffe wie z.B. pflegende, hautberuhigende, durchblu- tungsfördernde, pilzhemmende, befeuchtende oder geruchsabsorbierende Stoffe enthalten. Die genaue Zusammensetzung der Creme Hautschäume hängt von deren Verwendung ab. Der erfindungsgemässe Creme Hautschaum eignet sich auch zur Pflege gesunder, irritierter, trockener, rissiger, schuppiger oder im Abwehrverhalten geschädigter Haut. Ein weiteres Anwendungsgebiet des Creme Haut- schaums ist die Behandlung von Hautreizungen und/oderA cream skin foam of the present invention is distinguished by excellent skin tolerance, since it has a pH of 5.0 to 6.0. A cream of skin foam with a pH of 5.5 is particularly preferred. The advantage of the cream skin foam according to the invention lies in the maintenance of the physiological buffering capacity of the skin for the protection of bacterial and fungal infections while maintaining the natural bacterial skin flora and the integument. The partial saponification of the mixture in step d) means that the fatty acids of the creme skin foam are largely present as natural fatty acids, which corresponds to the composition of the physiological fat film of the skin. In the case of total saponification, the fatty acids would be present as soap (surfactants). The cream skin foams according to the invention can, in addition to the components described above, other Contain substances such as nourishing, skin-soothing, circulation-promoting, antifungal, moisturizing or odor-absorbing substances. The exact composition of the skin foam cream depends on its use. The cream skin foam according to the invention is also suitable for the care of healthy, irritated, dry, cracked, flaky skin or skin damaged in defense behavior. Another area of application of the cream skin foam is the treatment of skin irritation and / or
Schäden, die durch alkalische, kanzerogene, reizende oder die Epidermis auslaugende Stoffe hervorgerufen werden. Die Vorbeugung von Hautinfektionen, die durch Pilze, Sporen oder pathologische Keimbesiedlung, insbe- sondere Bakterien, hervorgerufen werden oder die Pflege der Haut nach erfolgter Hautinfektion lässt sich durch den erfingungsgemässen Creme Hautschaum erreichen. Der Creme Hautschäum kann auch zur Förderung der Hautdurchblutung und/oder zur Verbesserung des Haut- bildes beitragen. Zu diesem Zwecke erhält er bevorzugt pflanzliche Wirkstoffe. Die Erfindung wird nun mittels Beispielen weiter beschrieben. Herstellung eines Creme Hau schaumsDamage caused by alkaline, carcinogenic, irritating or leaching substances from the epidermis. The prevention of skin infections caused by fungi, spores or pathological microbial colonization, in particular bacteria, or the care of the skin after a skin infection has been achieved can be achieved with the skin foam cream according to the invention. The cream skin foam can also help to promote blood circulation to the skin and / or to improve the complexion. For this purpose, he preferably receives herbal active ingredients. The invention will now be further described by means of examples. Production of a cream foam
Die Komponenten der Oelphase im Elektrokessel zusammenwiegen und schmelzen, unter Rühren auf 73 bis 78°C heizen. Die Olphase enthält die folgenden Bestandteile (% w/w) : Miglyol 812 3, .4% Cetiol OE 1. .3% Mandelöl Suess Pharm 31433 3, .4% Weizenkeimöl 2010 1. .3% Cetiol LC 2. .6% Cuttina MD-V 1. .8% Lanette 0 Ph. Eur. 4.2% Edenor C 18 4.6% Nachtkerzenöl 2.0% Hostphat KW 340 D 0.9% Total 25.5%Weigh the components of the oil phase together in the electric boiler and melt them, heating to 73 to 78 ° C while stirring. The oil phase contains the following components (% w / w): Miglyol 812 3, .4% Cetiol OE 1. .3% almond oil Suess Pharm 31433 3, .4% wheat germ oil 2010 1. .3% Cetiol LC 2. .6% Cuttina MD-V 1. .8% Lanette 0 Ph. Eur. 4.2% Edenor C 18 4.6% Evening Primrose Oil 2.0% Hostphat KW 340 D 0.9% Total 25.5%
Dann in Becomix transferieren und Temperatur bei 73°-78°C halten.Then transfer to Becomix and keep the temperature at 73 ° -78 ° C.
Die Wasserphase im Elektrokessel zubereiten. Wasser De i- ner. Keimfrei vorlegen (58.9%) und die folgenden Komponenten zugeben und lösen: Propylenglycol 2.0% Glycerin 1.23 85% PH EUR II 3.0% Protelan LS 9011 2.3% Total 66.2%Prepare the water phase in the electric kettle. Water de i. Prepare aseptically (58.9%) and add and dissolve the following components: Propylene glycol 2.0% Glycerin 1.23 85% PH EUR II 3.0% Protelan LS 9011 2.3% Total 66.2%
Auf 73 - 78°C heizen. Becomix evakuieren und die Wasserphase im Umlauf, Stufe I zur Olphase einziehen. Dann Allantoin BPC Pulver 0.1% AMP (Aminomethylpropanol) 0.1% zugeben. 30 Min. mit Ankerrührer 30 UpM ausrühren (73-Heat to 73 - 78 ° C. Evacuate Becomix and draw in the water phase in circulation, stage I to the oil phase. Then add Allantoin BPC powder 0.1% AMP (Aminomethylpropanol) 0.1%. Stir for 30 min with anchor stirrer 30 rpm (73-
78°C) . Auf 25°C abkühlen und dann mit einer Puffermischung aus Milchsäure 90% PH. EUR. 2.5% Natronlauge 15% 5.4% den pH-Wert auf 5.5 einstellen. Mit Homogenisator Stufe I ausladen. Bei Miglyol 812, Cetiol OE, Cetiol LC, Cuttina MD-V, Lanette, Edenor C 18, Protelan und Hostphat KW 340D handelt es sich um im Handel erhältliche Produkte. Während in der vorliegenden Anmeldung bevorzugte Ausführungen der Erfindung beschrieben sind, ist klar darauf hinzuweisen, dass die Erfindung nicht auf diese beschränkt ist und in auch anderer Weise innerhalb des Umfangs der folgenden Ansprüche ausgeführt werden kann . 78 ° C). Cool to 25 ° C and then with a buffer mixture of lactic acid 90% PH. EUR. 2.5% sodium hydroxide 15% 5.4% adjust the pH to 5.5. Unload with level I homogenizer. Miglyol 812, Cetiol OE, Cetiol LC, Cuttina MD-V, Lanette, Edenor C 18, Protelan and Hostphat KW 340D are commercially available products. While preferred embodiments of the invention are described in the present application, it should be clearly pointed out that the invention is not limited to these and can also be carried out in other ways within the scope of the following claims.

Claims

Patentansprüche claims
1. Ein Creme Hautschaum erhältlich durch ein Verfahren, das folgende Schritte umfasst: a) Herstellung einer Olphase durch Aufschmelzen bei 70- 80°C einer Mischung umfassend Fettsäuren, bevorzugt Cg- C22 Fettsäuren, Fettalkohole und optional eine oder mehrere Ölkomponenten; b) Herstellung einer Wasserphase bei 70-80 °C umfassend Feuchthaltemittel, Emulgatoren und Coemulgatoren in Wasser; c) Vereinigung und Emulgierung der Wasserphase des Schritts b) mit der Olphase des Schritts a) bei 70- 80°C; d) Teilverseifung der in c) erhaltenen Mischung bei 70- 80°C; e) Einstellung des pH Werts der Mischung aus d) auf 5.0 bis 6.0 und f) Konfektionieren der Mischung aus e) durch Zugabe eines Treibgases. 1. A cream skin foam obtainable by a process comprising the following steps: a) production of an oil phase by melting at 70-80 ° C. of a mixture comprising fatty acids, preferably Cg-C22 fatty acids, fatty alcohols and optionally one or more oil components; b) Preparation of a water phase at 70-80 ° C comprising humectants, emulsifiers and co-emulsifiers in water; c) combining and emulsifying the water phase of step b) with the oil phase of step a) at 70-80 ° C; d) partial saponification of the mixture obtained in c) at 70-80 ° C; e) adjusting the pH of the mixture from d) to 5.0 to 6.0 and f) assembling the mixture from e) by adding a propellant.
2. Der Creme Hautschaum gemäss Anspruch 1, dadurch gekennzeichnet, dass die Olphase des Schritts a) den Fettalkohol Cetearylalkohol umfasst. 2. The cream skin foam according to claim 1, characterized in that the oil phase of step a) comprises the fatty alcohol cetearyl alcohol.
3. Der Creme Hautschaum gemäss Anspruch 1 oder 2, dadurch gekennzeichnet, dass die Olphase des3. The cream skin foam according to claim 1 or 2, characterized in that the oil phase of
Schritts a) Stearinsäure umfasst. Step a) comprises stearic acid.
4. Der Creme Hautschaun gemäss den Ansprüchen 1-3, dadurch gekennzeichnet, dass die Ölkomponente der Olphase des Schritts a) ausgewählt ist aus Fettsäuree- stern, Ölen, Mono-, Di- und Triglyceriden. 4. The cream skin scrub according to claims 1-3, characterized in that the oil component of the oil phase of step a) is selected from fatty acid esters, oils, mono-, di- and triglycerides.
5. Der Creme Hautschaum gemäss Anspruch 4, dadurch gekennzeichnet, dass die Öle der Olphase des Schritts a) ausgewählt sind aus Mandelöl, Nachtkerzenöl, Weizenkeimöl, Dicaprylether . 5. The cream skin foam according to claim 4, characterized in that the oils of the oil phase of step a) are selected from almond oil, evening primrose oil, wheat germ oil, dicapryl ether.
6. Der Creme Hautschaum gemäss Anspruch 4 oder 5, dadurch gekennzeichnet, dass die Triglyceride der Olphase des Schritts a) ausgewählt sind aus Caprylsäure- , Caprinsäure- und Stearinsäuretriglyceriden. 6. The cream skin foam according to claim 4 or 5, characterized in that the triglycerides The oil phase of step a) are selected from caprylic acid, capric acid and stearic acid triglycerides.
7. Der Creme Hautschaum gemäss den Ansprüchen 4-6, dadurch gekennzeichnet, dass die Fettsäureester der Olphase des Schritts a) ausgewählt sind aus Coco-Caprylat und Coco-Caprat. 7. The cream skin foam according to claims 4-6, characterized in that the fatty acid esters of the oil phase of step a) are selected from coco-caprylate and coco-caprate.
8. Der Creme Hautschaum gemäss den Ansprüchen 1-7, dadurch gekennzeichnet, dass die Herstellung der Olphase im Schritt a) bei 75°C geschieht und/oder die Her- Stellung der Wasserphase im Schritt b) bei 75 °C geschieht und/oder die Vereinigung und Emulgierung im Schritt c) bei 75°C geschieht und/oder die Teilverseifung im Schritt d) bei 75°C geschieht. 8. The cream skin foam according to claims 1-7, characterized in that the production of the oil phase in step a) takes place at 75 ° C and / or the production of the water phase in step b) takes place at 75 ° C and / or the combination and emulsification in step c) takes place at 75 ° C. and / or the partial saponification takes place in step d) at 75 ° C.
9. Der Creme Hautschaum gemäss den Ansprüchen 1-8, dadurch gekennzeichnet, dass nach dem Schritt c) der9. The cream skin foam according to claims 1-8, characterized in that after step c)
Mischung Wirkstoffe zugegeben werden, welche bevorzugt Allantoin umfassen. Mixture of active ingredients are added, which preferably comprise allantoin.
10. Der Creme Hautschaum gemäss den Ansprüchen 1-9, dadurch gekennzeichnet, dass die Feuchthal- temittel der Wasserphase des Schritts b) ausgewählt sind aus Glycerin und Propylenglycol . 10. The cream skin foam according to claims 1-9, characterized in that the humectants of the water phase of step b) are selected from glycerol and propylene glycol.
11. Der Creme Hautschaum gemäss den Ansprüchen 1-10, dadurch gekennzeichnet, dass die Emulgatoren bzw. Coemulgatoren ausgewählt sind aus Triceteareth-4 Phosphat und Natriu lauroylsarkosinat . 11. The cream skin foam according to claims 1-10, characterized in that the emulsifiers or co-emulsifiers are selected from triceteareth-4 phosphate and natriu lauroylsarcosinate.
12. Der Creme Hautschaum gemäss den Ansprüchen 1-11, dadurch gekennzeichnet, dass die Teilverseifung im Schritt d) mittels Aminomethylpropanol oder Triethanolamin geschieht, bevorzugt durch ausrühren für 30 Minuten. 12. The cream skin foam according to claims 1-11, characterized in that the partial saponification in step d) is carried out using aminomethylpropanol or triethanolamine, preferably by stirring for 30 minutes.
13. Der Creme Hautschaum gemäss den Ansprüchen 1-12, dadurch gekennzeichnet, dass die Einstellung des pH-Wertes im Schritt e) durch Zugabe eines Milchsäure/Natronlauge Puffers geschieht. 13. The cream skin foam according to claims 1-12, characterized in that the pH is adjusted in step e) by adding a lactic acid / sodium hydroxide buffer.
14. Der Creme Hautschaum gemäss den Ansprüchen 1-13, dadurch gekennzeichnet, dass die Einstellung des pH-Wertes im Schritt e) bei einer Temperatur, die unterhalb 30°C liegt, bevorzugt bei 25°C, geschieht. 14. The cream skin foam according to claims 1-13, characterized in that the setting of the pH in step e) at a temperature which is below 30 ° C, preferably at 25 ° C.
15. Der Creme Hautschaum gemäss den Ansprüchen 1-14, dadurch gekennzeichnet, dass die Konfektionie- rung im Schritt f) durch Zugabe von Propan und/oder Butan geschieht . 15. The cream skin foam according to claims 1-14, characterized in that the assembly in step f) is done by adding propane and / or butane.
16. Der Creme Hautschaum gemäss den Ansprüchen 1-15 als Hautpflegemittel. 16. The cream skin foam according to claims 1-15 as a skin care product.
17. Verwendung eines Creme Hautschaums gemäss den Ansprüchen 1-15 zur Herstellung eines Mittels zur17. Use of a cream skin foam according to claims 1-15 for the preparation of an agent for
Pflege gesunder, irritierter, trockener, rissiger, schuppiger oder im Abwehrverhalten geschädigter Haut. Care for healthy, irritated, dry, cracked, flaky or defective skin.
18. Verwendung eines Creme Hautschaums gemäss den Ansprüchen 1-15 zur Herstellung eines Mittels zur Be- handlung von Hautreizungen und/oder Schäden, die durch alkalische, kanzerogene, reizende oder die Epidermis auslaugende Stoffe hervorgerufen werden. 18. Use of a cream skin foam according to claims 1-15 for the production of an agent for the treatment of skin irritation and / or damage caused by alkaline, carcinogenic, irritating or leaching the epidermis.
19. Verwendung eines Creme Hautschaums gemäss den Ansprüchen 1-15 zur Herstellung eines Mittels zur Vorbeugung von Hautinfektionen, die durch Pilze, Sporen oder pathologische Keimbesiedlung, insbesondere Bakterien, hervorgerufen werden oder zur Hautpflege nach erfolgter Hautinfektion. 19. Use of a cream skin foam according to claims 1-15 for the production of an agent for the prevention of skin infections caused by fungi, spores or pathological microorganisms, in particular bacteria, or for skin care after a skin infection.
20. Verwendung eines Creme Hautschaums gemäss den Ansprüchen 1-15 zur Herstellung eines Mittels zur20. Use of a cream skin foam according to claims 1-15 for the preparation of an agent for
Förderung der Hautdurchblutung und/oder zur Verbesserung des Hautbildes. Promote blood circulation to the skin and / or to improve the complexion.
PCT/IB2003/005006 2003-11-05 2003-11-05 Foamed skin cream WO2005044215A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2003/005006 WO2005044215A1 (en) 2003-11-05 2003-11-05 Foamed skin cream
AU2003274610A AU2003274610A1 (en) 2003-11-05 2003-11-05 Foamed skin cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/005006 WO2005044215A1 (en) 2003-11-05 2003-11-05 Foamed skin cream

Publications (1)

Publication Number Publication Date
WO2005044215A1 true WO2005044215A1 (en) 2005-05-19

Family

ID=34566854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/005006 WO2005044215A1 (en) 2003-11-05 2003-11-05 Foamed skin cream

Country Status (2)

Country Link
AU (1) AU2003274610A1 (en)
WO (1) WO2005044215A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007036376A2 (en) * 2005-09-28 2007-04-05 Neubourg Skin Care Gmbh & Co. Kg Skincare products
FR2970426A1 (en) * 2011-01-19 2012-07-20 Raphael Colicci NATURAL EMULSION AND PROCESS FOR PREPARING THE SAME
US8673278B2 (en) 2006-05-26 2014-03-18 Dr. Holmquist Healthcare, L.L.C. Bruise amelioration composition and method of use
EP2701671B1 (en) 2011-04-28 2016-03-16 Tunap Industrie Chemie GmbH & Co. Produktions KG Ow emulsion concentrate, process for the manufacture thereof and cosmetic for the skin containing said concentrate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674804A5 (en) * 1988-02-05 1990-07-31 Battelle Memorial Institute Homogeneous stale cosmetic cream as light foam - contains dispersed fine bubbles of air or inert gas
WO1999008649A2 (en) * 1997-08-18 1999-02-25 Neubourg, Stephanie Foaming skin cream
WO1999047106A1 (en) * 1998-03-16 1999-09-23 Alterna, Inc. Quaternized hemp seed oil
DE10113047A1 (en) * 2001-03-15 2002-09-26 Beiersdorf Ag Self-foaming or foam-producing cosmetic composition, useful for skin or hair care, comprises gas, lipid, thickener and three-component emulsifier system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674804A5 (en) * 1988-02-05 1990-07-31 Battelle Memorial Institute Homogeneous stale cosmetic cream as light foam - contains dispersed fine bubbles of air or inert gas
WO1999008649A2 (en) * 1997-08-18 1999-02-25 Neubourg, Stephanie Foaming skin cream
WO1999047106A1 (en) * 1998-03-16 1999-09-23 Alterna, Inc. Quaternized hemp seed oil
DE10113047A1 (en) * 2001-03-15 2002-09-26 Beiersdorf Ag Self-foaming or foam-producing cosmetic composition, useful for skin or hair care, comprises gas, lipid, thickener and three-component emulsifier system

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007036376A2 (en) * 2005-09-28 2007-04-05 Neubourg Skin Care Gmbh & Co. Kg Skincare products
WO2007036376A3 (en) * 2005-09-28 2007-09-20 Neubourg Skin Care Gmbh & Co K Skincare products
EP2238977A2 (en) * 2005-09-28 2010-10-13 Neubourg Skin Care GmbH & Co. KG Skin cleaning products
EP2238977A3 (en) * 2005-09-28 2010-12-22 Neubourg Skin Care GmbH & Co. KG Skincare products
US8673278B2 (en) 2006-05-26 2014-03-18 Dr. Holmquist Healthcare, L.L.C. Bruise amelioration composition and method of use
FR2970426A1 (en) * 2011-01-19 2012-07-20 Raphael Colicci NATURAL EMULSION AND PROCESS FOR PREPARING THE SAME
WO2012098336A1 (en) * 2011-01-19 2012-07-26 Totum Bio Cosmetics Natural emulsion and production method thereof
EP2701671B1 (en) 2011-04-28 2016-03-16 Tunap Industrie Chemie GmbH & Co. Produktions KG Ow emulsion concentrate, process for the manufacture thereof and cosmetic for the skin containing said concentrate

Also Published As

Publication number Publication date
AU2003274610A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
EP1014916B2 (en) Foaming skin cream, uses thereof and a method for producing the same
DE69210515T2 (en) Cosmetic products
DE69807926T2 (en) SKIN CARE WITH IMPROVED SKIN HYDRATION
US5939085A (en) Skin smoothing compositions containing hydroxyacids and methods for using same
DE60206140T2 (en) Anhydrous cosmetic or pharmaceutical two-phase compositions containing an anhydrous hydrophilic external phase, an internal oil phase and a gelling agent
EP0166522B1 (en) Cosmetic preparation
DE19857492A1 (en) Cosmetic or dermatological skin-protective compositions, containing saturated phosphatidyl choline to give good barrier stabilizing and active agent penetrating effects
EP1638513B1 (en) Use of a composition comprising unsaponifiable materials
EP2493447B1 (en) Human sebum mimetics derived from botanical sources and methods for making the same
CN112022760A (en) Cleansing oil with skin care effect and preparation method thereof
DE2408663C2 (en)
CN113230170A (en) Double-continuous-phase cleansing oil with effects of cleaning and nourishing skin and preparation method thereof
DE60114272T2 (en) Use of special fatty substances with which the physico-chemical properties of the skin and / or the mucous membranes can be changed, as active ingredients that prevent or reduce the adhesion of microorganisms
DE69520406T2 (en) Agent for topical use containing a lipase and a hydroxy acid precursor
WO2020160742A1 (en) Active agents for skin and hair care with sensory modifying properties
JP5912397B2 (en) Cosmetic liquid, cosmetic liquid production method and cosmetic method
WO2005044215A1 (en) Foamed skin cream
DE19857491A1 (en) Cosmetic or dermatological skin-protective compositions, containing UV filter and saturated phosphatidyl choline to give good barrier stabilizing and active agent penetrating effects
DE69903959T2 (en) COSMETIC PREPARATIONS
DE69500018T2 (en) Oily peeling gel
JP3557544B2 (en) Horny soft cosmetic
EP2705828B1 (en) Quick-penetrating, soft skin care cream
JP3740090B2 (en) Water-in-oil external preparation
JP3573337B2 (en) Emulsion cosmetic for hair
JPH11302147A (en) Cosmetic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP